Professor Copson is a clinical academic and Honorary Consultant in Medical Oncology at the University of Southampton, where she treats patients with early and advanced breast cancer. She developed her interest in cancer genomics following a PhD investigating heritable breast cancer and is oncology lead for several research studies investigating the impact of genomic and modifiable host factors on outcomes of early breast cancer, including the POSH study, a large national cohort study of young breast cancer patients. Dr Copson has been co-chair of the Wessex Molecular Tumour Board since 2017 and cancer lead of the West Midlands, Oxford and South Central Genomic Laboratory Hub since October 2021. She is the oncology advisor for the educational workstream of the ‘CanGene-CanVar research program and oncology lead for the Health Education England GeNotes educational resource initiative.